U.S. Averaging Nearly 1M Vaccine Doses a Day; Booster, Mandates Likely Driving Demand
The number of COVID-19 vaccines being jabbed into American arms is at a three-month high now that seniors and people with medical conditions are approved for boosters, and government and employer mandates encourage more workers to get their doses.
The U.S. is reaching an average of 1 million doses administered a day, twice as many as mid-July. That estimate is still below last spring, when the vaccine first became available to the general public.
Organizers in charge of reaching the 67 million or so unvaccinated American adults are pointing toward the approval of the COVID-19 booster and workplace and government mandates. Bleak statistics showing COVID-19 deaths are also likely contributors.

For more reporting from the Associated Press, see below.
On Thursday, 1.1 million doses were delivered, including just over 306,000 to newly vaccinated people, said Dr. Cyrus Shahpar, the White House COVID-19 data director.
Demand is expected to spike in a few weeks when elementary school children can begin getting shots, and some states are reopening mass vaccination clinics in anticipation.
In Missouri, a mass vaccination site at a former Toys R Us store is set to open Monday. Virginia plans to roll out nine large vaccination centers over the next few weeks, including one at the Richmond International Raceway.
Colorado opened four mass vaccination sites in mid-September, largely to deal with employer mandates, and officials saw a 38 percent increase in vaccinations statewide during the first week.
"We're seeing people who need the shot to keep a job," said Dr. Ricardo Gonzalez-Fisher, who runs a mobile vaccine clinic mostly for Latinos in Colorado.
Last weekend, his clinic delivered 30 shots to people outside the Mexican Consulate in Denver. "On these days, 30 is a very good number," he said.
Virginia's state vaccine coordinator, Dr. Danny Avula, said opening the large vaccination centers, will allow local health departments to focus on reaching underserved communities. "This should really help relieve the burden for our local providers," he said.
Last week, the number of people getting shots at a mall in Charlottesville, Virginia, doubled over the previous week, said Ryan McKay, who oversees COVID-19 operations for the Blue Ridge Health District.
The big push now, he said, is in neighborhoods where rates are low. The health district has set up mobile clinics at weekend basketball tournaments, high school football games and even at a corner market where 20 people were vaccinated in a day.
"Those 20 vaccinations sound small, but it's really a huge success," McKay said.
On Friday, Vice President Kamala Harris stopped at a vaccine center in Newark, New Jersey, where she met with patients and health care workers and encouraged people to get the shot.
"There will be an end to this," she said. "We really feel we are starting to get in front of this."
In Ohio, Alba Lopez decided to get the Pfizer vaccine on Friday at the Columbus Public Health Department after tiring of twice-weekly testing required by her employer, Chase Bank, and filling out an online form each day indicating whether she had a fever and how she felt.
The vaccine "helped me to avoid all that," said Lopez, who also figured her company will eventually require it.
Health officials in Springfield, Missouri, an early epicenter of the Delta surge, are opening the new vaccination site at the former toy store because they anticipate seeing an influx of people.
"All told, in the coming weeks and months, we are expecting more than 120,000 people to seek vaccine," said Jon Mooney, assistant director of the Springfield-Greene County Health Department. "We are already experiencing increased demand in the last week or two."
Cases in the Springfield area are falling, but 78 people remain hospitalized in the city, and federal officials have determined that community transmission remains high.
Mitchell Maccarone, 24, got his second shot Thursday at a CVS Pharmacy in North Smithfield, Rhode Island. He wanted to wait until the vaccine received full FDA approval.
"Before I put something in my body, I want to make sure it's fully approved," he said. "I'm also not in a high-risk age group. I am healthy, and I had COVID, and it was really just the sniffles."
Vaccination sites that opened within the past week in Memphis, Tennessee, and Tampa, Florida, drew mostly people seeking booster shots and only a handful of people getting their first or second shots, said organizers who expect demand to rise.
A bump in vaccinations in Louisiana began in August, when so many were getting sick from the highly contagious Delta variant, said Sheree Taillon, vaccine incentive coordinator for the state's health department.
But now there are few first-timers seeking shots, and most people coming for their boosters are older people and those who rushed to get vaccinated last winter, she said. And COVID-19 deaths and hospitalizations are dropping.
"The fear is leaving yet again," she said. "I feel that fear is the only thing to get folks vaccinated at this point."